Related Experiment Videos
The long-term pathological evolution of chronic hepatitis C
1Nagasaki Chuo National Institute for Clinical Research, Ohmura-shi, Japan.
Hepatology (Baltimore, Md.)
|June 1, 1996
Summary
Hepatitis C virus (HCV) patients with high-grade necroinflammation or advanced fibrosis on initial liver biopsy are at high risk for cirrhosis progression. Early biopsy grading and staging are crucial for predicting long-term outcomes in chronic hepatitis C.
Area of Science:
- Hepatology
- Virology
- Pathology
Background:
- Chronic hepatitis C virus (HCV) infection often leads to long-term liver damage.
- The precise pathological progression of chronic hepatitis C remains incompletely understood.
- Liver biopsy is a key diagnostic tool for assessing disease severity.
Purpose of the Study:
- To investigate the correlation between initial liver biopsy findings and the long-term progression of chronic hepatitis C.
- To determine the predictive value of necroinflammation grade and fibrosis stage for cirrhosis development.
- To identify specific histopathological features associated with accelerated cirrhosis progression.
Main Methods:
- Retrospective analysis of liver biopsy specimens from 70 HCV-positive patients.
- Independent evaluation of biopsy specimens by four pathologists, assessing necroinflammation (grade 0-4) and fibrosis (stage 1-4).
- Correlation of initial biopsy scores with disease progression and cirrhosis development over a mean follow-up of 8.8 years.
Main Results:
- 50% of patients developed cirrhosis during follow-up.
- High initial necroinflammation grade (≥5) predicted cirrhosis within 10 years.
- Advanced fibrosis stage (3.0-3.4) indicated progression to unequivocal cirrhosis by 10 years.
- Higher initial grades and stages of liver lesions accelerated cirrhosis progression.
Conclusions:
- Liver biopsy grading and staging are critical for predicting cirrhosis risk in chronic hepatitis C.
- Patients with high-grade necroinflammation, septal fibrosis, or modularity on initial biopsy face a significantly higher risk of advanced cirrhosis.
- Early identification of high-risk patients through biopsy assessment is essential for timely clinical management.